EQ-5D-derived health utility values in patients undergoing surgery for chronic rhinosinusitis

Laryngoscope

Volumn 125, Issue 5, 2015, Pages 1056-1061

  Remenschneider, Aaron K ^a   Scangas, George ^a   Meier, Josh C ^a   Gray, Stacey T ^a   Holbrook, Eric H ^a   Gliklich, Richard E ^a   Metson, Ralph ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chronic rhinosinusitis; EQ 5D; health utility; quality adjusted life years; quality of life

Indexed keywords

ADULT; AGED; CHRONIC RHINOSINUSITIS; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONFERENCE PAPER; COST UTILITY ANALYSIS; ENDOSCOPIC SINUS SURGERY; EUROQOL 5 DIMENSION; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SURGICAL PATIENT; UNITED STATES; VISUAL ANALOG SCALE; CHRONIC DISEASE; COMPLICATION; DAILY LIFE ACTIVITY; EAR NOSE THROAT SURGERY; FOLLOW UP; HEALTH STATUS INDICATOR; MIDDLE AGED; PATIENT SATISFACTION; PROCEDURES; PSYCHOLOGY; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; RHINITIS; SINUSITIS; TIME; UTILIZATION;

ACTIVITIES OF DAILY LIVING; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; RHINITIS; SINUSITIS; TIME FACTORS;

EID: 84928541025     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.25054     Document Type: Conference Paper

References (43)

1. Essink-Bot ML, Stouthard ME, Bonsel GJ,. Generalizability of valuations on health states collected with the EuroQolc-questionnaire. Health Econ 1993; 2: 237-246.
2. Brooks R,. EuroQol: the current state of play. Health Policy 1996; 37: 53-72.
3. Rudmik L, Drummond M,. Health economic evaluation: important principles and methodology. Laryngoscope 2013; 123: 1341-1347.
4. Remenschneider AK, D'Amico L, Gray ST, Holbrook EH, Gliklich RE, Metson R,. The EQ-5D-a new tool for studying clinical outcomes in chronic rhinosinusitis. Laryngoscope 2014. doi: 10.1002/lary.24715. Epub ahead of print.
5. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011; 20: 1727-1736.
6. EQ-5D-5L value sets. Available at: http://www.euroqol.org/about-eq-5d/valuation-of-eq-5d/eq-5d-5l-value-sets.html. Accessed May 27, 2014.
7. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007; 137: S1-S31.
8. Remenschneider AK, D'Amico L, Litvack JR, et al. Long-term outcomes in sinus surgery: a new tool for measuring health-related quality of life. Otolaryngol Head Neck Surg 2014; 151: 64-170.
9. Meier JC, Remenschneider AK, D'Amico L, Holbrook EH, Gray ST, Metson R,. A new model for collection of clinical outcomes data in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol 2014; 4: 411-415. doi: 10.1002/alr.21282.
10. Janssen MF, Pickard AS, Golicki D, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 2012; 22: 1717-1727.
11. Shaw JW, Johnson JA, Coons SJ,. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005; 43: 203-220.
12. Dolan P,. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-1108.
13. Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG,. Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Making 2006; 26: 391-400.
14. Sullivan PW, Lawrence WF, Ghushchyan V,. A national catalog of preference-based scores for chronic conditions in the United States. Med Care 2005; 43: 736-749.
15. Walters SJ, Brazier JE,. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005; 14: 1523-1532.
16. Norman GR, Sloan JA, Wyrwich KW,. The truly remarkable universality of half a standard deviation: confirmation through another look. Expert Rev Pharmacoecon Outcomes Res 2004; 4: 581-585.
17. Pickard AS, Yang Y, Lee TA,. Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes 2011; 9: 26.
18. Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU,. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 2006; 130: 1117-1128.
19. Ko Y, Coons SJ,. Self-reported chronic conditions and EQ-5D index scores in the US adult population. Curr Med Res Opin 2006; 22: 2065-2071.
20. Chen H, Gould MK, Blanc PD, et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007; 120: 396-402.
21. Russell RT, Feurer ID, Wisawatapnimit P, Pinson CW,. The validity of EQ-5D US preference weights in liver transplant candidates and recipients. Liver Transpl 2009; 15: 88-95.
22. Wolfe F, Michaud K, Li T, Katz RS,. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol 2010; 37: 296-304.
23. Freedman GM, Li T, Anderson PR, Nicolaou N, Konski A,. Health states of women after conservative surgery and radiation for breast cancer. Breast Cancer Res Treat 2010; 121: 519-526.
24. King JT Jr, Tsevat J, Roberts MS,. Measuring preference-based quality of life using the EuroQol EQ-5D in patients with cerebral aneurysms. Neurosurgery 2009; 65: 565-572; discussion 572-563.
25. Joyce VR, Barnett PG, Chow A, et al. Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trial. Med Decis Making 2012; 32: 70-82.
26. Zhang P, Brown MB, Bilik D, Ackermann RT, Li R, Herman WH,. Health utility scores for people with type 2 diabetes in U.S. managed care health plans: results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care 2012; 35: 2250-2256.
27. Fu AZ, Qiu Y, Radican L, Luo N,. Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States. Qual Life Res 2011; 20: 825-832.
28. Ellis JJ, Eagle KA, Kline-Rogers EM, Erickson SR,. Validation of the EQ-5D in patients with a history of acute coronary syndrome. Curr Med Res Opin 2005; 21: 1209-1216.
29. Garster NC, Palta M, Sweitzer NK, Kaplan RM, Fryback DG,. Measuring health-related quality of life in population-based studies of coronary heart disease: comparing six generic indexes and a disease-specific proxy score. Qual Life Res 2009; 18: 1239-1247.
30. Sullivan PW, Ghushchyan VH, Ben-Joseph R,. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res 2008; 17: 1063-1071.
31. Jia H, Lubetkin EI,. The impact of obesity on health-related quality-of-life in the general adult US population. J Public Health (Oxf) 2005; 27: 156-164.
32. Korobkin R,. Relative value health insurance. J Health Polit Policy Law 2014; 39: 417-440.
33. Feeny D, Torrance GW, Furlong WJ,. Health utilities index. In:, Spiker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA: Lippincott-Raven; 1996: 239-252.
34. Kaplan RM, Bush JW, Berry CC,. Health status: types of validity and the index of well-being. Health Serv Res 1976; 11: 478-507.
35. Brazier J, Roberts J, Deverill M,. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002; 21: 271-292.
36. McDonough CM, Tosteson AN,. Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. Pharmacoeconomics 2007; 25: 93-106.
37. Fryback DG, Dunham NC, Palta M, et al. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care 2007; 45: 1162-1170.
38. Soler ZM, Wittenberg E, Schlosser RJ, Mace JC, Smith TL,. Health state utility values in patients undergoing endoscopic sinus surgery. Laryngoscope 2011; 121: 2672-2678.
39. Rudmik L, Mace J, Soler ZM, Smith TL,. Long-term utility outcomes in patients undergoing endoscopic sinus surgery. Laryngoscope 2014; 124: 19-23.
40. Chapman JR, Norvell DC, Hermsmeyer JT, et al. Evaluating common outcomes for measuring treatment success for chronic low back pain. Spine 2011; 36: S54-68.
41. Gaujoux-Viala C, Rat AC, Guillemin F, et al. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort. J Rheumatol 2011; 38: 1576-1584.
42. U.S. Valuation of the EuroQol EQ-5D Health States. Agency for Healthcare Research and Quality, Rockville, MD: 2012. Updated January 2012. http://www.ahrq.gov/rice/EQ5Dproj.htm. Accessed May 27, 2014.
43. Gliklich RE, Metson R,. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 1995; 113: 104-109.